{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:23:49Z","timestamp":1774542229588,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:00:00Z","timestamp":1626048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:00:00Z","timestamp":1626048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The entry of PCR-based techniques into malaria diagnostics has improved the sensitivity and specificity of the detection of <jats:italic>Plasmodium<\/jats:italic> infections. It has been shown that humans are regularly infected by at least six different <jats:italic>Plasmodium<\/jats:italic> species. The MC004 real-time PCR assay for malaria diagnosis is a novel single-tube assay that has been developed for the purpose of simultaneously detecting all <jats:italic>Plasmodium<\/jats:italic> species known to infect humans, and discrimination between <jats:italic>Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae, Plasmodium ovale wallikeri<\/jats:italic>, <jats:italic>Plasmodium ovale curtisi<\/jats:italic>, <jats:italic>Plasmodium knowlesi<\/jats:italic> (including differentiation of three strains) and <jats:italic>Plasmodium cynomolgi<\/jats:italic> (including differentiation of three strains). Detection and identification of <jats:italic>Plasmodium<\/jats:italic> species relies on molecular beacon probe-based melting curve analysis. In addition, this assay might be used to quantify the parasitaemia of at least <jats:italic>P. falciparum<\/jats:italic> by calculating the level of parasitaemia directly from the Cq-value.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The samples used in this study comprised reference samples, patient samples, and synthetic controls. The following analytical performance characteristics of the MC004 assay were determined: analytical specificity, limit of detection, the ability to detect mixed infections, and the potential to determine the level of parasitaemia of <jats:italic>P. falciparum<\/jats:italic>, including assessment of within-run and between-run precisions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>No false positive or false negative results were observed. The limit of detection of <jats:italic>P. falciparum<\/jats:italic> was 1\u2009\u00d7\u200910<jats:sup>\u20133<\/jats:sup>\u00a0IU\/mL (WHO standard). Mixed infections with <jats:italic>P. falciparum<\/jats:italic> and non-<jats:italic>falciparum<\/jats:italic> species were correctly identified. A calibration curve could be established to quantify the parasitaemia of at least <jats:italic>P. falciparum<\/jats:italic>. The within-run and between-run precisions were less than 20% CV at the tested parasitaemia levels of 0.09%, 0.16%, 2.15% and 27.27%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Based upon the analytical performance characteristics that were determined, the MC004 assay showed performance suitable for use in clinical settings, as well as epidemiological studies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12936-021-03842-8","type":"journal-article","created":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T03:10:35Z","timestamp":1626059435000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Evaluation of a novel real-time PCR assay for the detection, identification and quantification of Plasmodium species causing malaria in humans"],"prefix":"10.1186","volume":"20","author":[{"given":"Kim","family":"van Bergen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toon","family":"Stuitje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Akkers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Vermeer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1142-1583","authenticated-orcid":false,"given":"Rob","family":"Castel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theo","family":"Mank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,12]]},"reference":[{"key":"3842_CR1","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/S0140-6736(18)30324-6","volume":"391","author":"EA Ashley","year":"2018","unstructured":"Ashley EA, Phyo AP, Woodrow CJ. Malaria. Lancet. 2018;391:608\u201321.","journal-title":"Lancet"},{"key":"3842_CR2","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1086\/652240","volume":"201","author":"CJ Sutherland","year":"2010","unstructured":"Sutherland CJ, Tanomsing N, Nolder D, Oguike M, Jennison C, Pukrittayakamee S, et al. Two nonrecombining sympatric forms of the human malaria parasite Plasmodium ovale occur globally. J Infect Dis. 2010;201:1544\u201350.","journal-title":"J Infect Dis"},{"key":"3842_CR3","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/infdis\/jiy520","volume":"219","author":"NM Anstey","year":"2019","unstructured":"Anstey NM, Grigg MJ. Zoonotic malaria: the better you look, the more you find. J Infect Dis. 2019;219:679\u201381.","journal-title":"J Infect Dis"},{"key":"3842_CR4","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/infdis\/jiy519","volume":"219","author":"M Imwong","year":"2019","unstructured":"Imwong M, Madmanee W, Suwannasin K, Kunasol C, Peto TJ, Tripura R, et al. Asymptomatic natural human infections with the simian malaria parasites Plasmodium cynomolgi and Plasmodium knowlesi. J Infect Dis. 2019;219:695\u2013702.","journal-title":"J Infect Dis"},{"key":"3842_CR5","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.ebiom.2015.07.033","volume":"2","author":"A Lalremruata","year":"2015","unstructured":"Lalremruata A, Magris M, Vivas-Martinez S, Koehler M, Esen M, Kempaiah P, et al. Natural infection of Plasmodium brasilianum in humans: man and monkey share quartan malaria parasites in the Venezuelan Amazon. EBioMedicine. 2015;2:1186\u201392.","journal-title":"EBioMedicine"},{"key":"3842_CR6","doi-asserted-by":"publisher","first-page":"e1038","DOI":"10.1016\/S2214-109X(17)30333-9","volume":"5","author":"P Brasil","year":"2017","unstructured":"Brasil P, Zalis MG, Pina-Costa AD, Siquira AM, Junior CB, Silva S, et al. Outbreak of human malaria caused by Plasmodium simium in the Atlantic Forest in Rio de Janeiro: a molecular epidemiological investigation. Lancet Glob Health. 2017;5:e1038\u201346.","journal-title":"Lancet Glob Health"},{"key":"3842_CR7","doi-asserted-by":"publisher","first-page":"e961","DOI":"10.1016\/S2214-109X(17)30343-1","volume":"5","author":"MJ Grigg","year":"2017","unstructured":"Grigg MJ, Snounou G. Plasmodium simium: a Brazilian focus of anthropozoonotic vivax malaria? Lancet Glob Health. 2017;5:e961\u20132.","journal-title":"Lancet Glob Health"},{"key":"3842_CR8","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1128\/JCM.02562-16","volume":"55","author":"BA Mathison","year":"2017","unstructured":"Mathison BA, Pritt BS. Update on malaria diagnostics and test utilization. J Clin Microbiol. 2017;55:2009\u201317.","journal-title":"J Clin Microbiol"},{"key":"3842_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00436-018-6127-9","volume":"118","author":"JA Garrido-Cardenas","year":"2019","unstructured":"Garrido-Cardenas JA, Gonzalez-Ceron L, Manzano-Agugliaro F, Mesa-Valle C. Plasmodium genomics: an approach for learning about and ending human malaria. Parasitol Res. 2019;118:1\u201327.","journal-title":"Parasitol Res"},{"key":"3842_CR10","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1093\/cid\/cir180","volume":"52","author":"A Kantele","year":"2011","unstructured":"Kantele A, Jokiranta TS. Review of cases with the emerging fifth human malaria parasite Plasmodium knowlesi. Clin Infect Dis. 2011;52:1356\u201362.","journal-title":"Clin Infect Dis"},{"key":"3842_CR11","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1186\/s12936-015-0985-8","volume":"14","author":"J Chavatte","year":"2015","unstructured":"Chavatte J, Tan SBH, Snounou G, Lin RTBV. Molecular characterization of misidentified Plasmodium ovale imported cases in Singapore. Malar J. 2015;14:454.","journal-title":"Malar J"},{"key":"3842_CR12","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1080\/14787210.2019.1693259","volume":"17","author":"J Cheaveau","year":"2019","unstructured":"Cheaveau J, Mogollon DJ, Mohon MAN, Golassa L, Yewhalaw D, Pillai DR. Asymptomatic malaria in the clinical and public health context. Expert Rev Anti Infect Therapy. 2019;17:997\u20131010.","journal-title":"Expert Rev Anti Infect Therapy"},{"key":"3842_CR13","doi-asserted-by":"publisher","first-page":"e1001942","DOI":"10.1371\/journal.pmed.1001942","volume":"13","author":"I Chen","year":"2016","unstructured":"Chen I, Clarke SE, Gosling R, Hamainza B, Killeen G, Magill A, et al. \"Asymptomatic\u201d malaria: a chronic and debilitating infection that should be treated. PLoS Med. 2016;13:e1001942.","journal-title":"PLoS Med"},{"key":"3842_CR14","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.4269\/ajtmh.17-0167","volume":"97","author":"F Huang","year":"2017","unstructured":"Huang F, Takala-Harrison S, Liu H, Xu J, Yang H, Adams M, et al. Prevalence of clinical and subclinical Plasmodium falciparum and Plasmodium vivax malaria in two remote rural communities on the Myanmar-China border. Am J Trop Med Hyg. 2017;97:1524\u201331.","journal-title":"Am J Trop Med Hyg"},{"key":"3842_CR15","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/nrmicro3364","volume":"12","author":"T Bousema","year":"2014","unstructured":"Bousema T, Okell L, Felger I, Drakeley C. Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat Rev Microbiol. 2014;12:833\u201340.","journal-title":"Nat Rev Microbiol"},{"key":"3842_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12936-020-03200-0","volume":"19","author":"JA Cunningham","year":"2020","unstructured":"Cunningham JA, Thomson RM, Murphy SC, Paz Ade MDI, Ding XC, Incardona S, et al. WHO malaria nucleic acid amplification test external quality assessment scheme: results of distribution programmes one to three. Malar J. 2020;19:129.","journal-title":"Malar J"},{"key":"3842_CR17","first-page":"e0097398","volume":"9","author":"SC Murphy","year":"2014","unstructured":"Murphy SC, Hermsen C, Douglas AD, Edwards NJ, Petersen I, Fahle GA, et al. External quality assurance of malaria nucleic acid testing for clinical trials and eradication surveillance. PLoS ONE. 2014;9:e0097398.","journal-title":"PLoS ONE"},{"key":"3842_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.cll.2013.03.008","volume":"33","author":"S Vasoo","year":"2013","unstructured":"Vasoo S, Pritt BS. Molecular diagnostics and parasitic disease. Clin Lab Med. 2013;33:461\u2013503.","journal-title":"Clin Lab Med"},{"key":"3842_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1475-2875-7-139","volume":"7","author":"D Padley","year":"2008","unstructured":"Padley D, Health A, Sutherland C, Chiodini P, Baylis S, Collaborative Study Group. Establishment of the 1st World Health Organization International Standard for Plasmodium falciparum DNA for nucleic acid amplification technique (NAT)-based assays. Malar J. 2008;7:139.","journal-title":"Malar J"},{"issue":"Suppl 1","key":"3842_CR20","first-page":"S23","volume":"29","author":"D Chesher","year":"2008","unstructured":"Chesher D. Evaluating assay precision. Clin Biochem Rev. 2008;29(Suppl 1):S23\u20136.","journal-title":"Clin Biochem Rev"},{"key":"3842_CR21","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1128\/JCM.02156-10","volume":"49","author":"C Farrugia","year":"2011","unstructured":"Farrugia C, Cabaret O, Botterel, Bories C, Foulet F, Costa J, et al. Cytochrome b gene quantitative PCR for diagnosing Plasmodium falciparum infection in travelers. J Clin Microbiol. 2011;49:2191\u20135.","journal-title":"J Clin Microbiol"},{"key":"3842_CR22","doi-asserted-by":"publisher","first-page":"e01566","DOI":"10.1128\/genomeA.01566-16","volume":"5","author":"E Talundzic","year":"2017","unstructured":"Talundzic E, Ravishankar S, Nayak V, Patel DS, Olsen C, Sheth M, et al. First full draft genome sequence of Plasmodium brasilianum. Genome Announc. 2017;5:e01566-e1616.","journal-title":"Genome Announc"},{"key":"3842_CR23","first-page":"124","volume":"50","author":"C Leblanc","year":"2020","unstructured":"Leblanc C, Vasse C, Minodier P, Mornand P, Naudin J, Quinet B, et al. Management and prevention of imported malaria in children. Update of the French guidelines. Med Mal Infect. 2020;50:124\u2013214.","journal-title":"Med Mal Infect"},{"key":"3842_CR24","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jinf.2016.02.001","volume":"72","author":"D Lalloo","year":"2016","unstructured":"Lalloo D, Shingadia D, Bell D, Beeching N, Whitty C, Chiodini P, et al. UK malaria treatment guidelines 2016. J Infect. 2016;72:635\u201349.","journal-title":"J Infect"},{"key":"3842_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/tmi.12313_2","volume":"19","author":"WHO","year":"2014","unstructured":"WHO. Severe malaria. Trop Med Int Health. 2014;19:7\u2013131.","journal-title":"Trop Med Int Health"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-021-03842-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-021-03842-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-021-03842-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T03:13:40Z","timestamp":1626059620000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-021-03842-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,12]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3842"],"URL":"https:\/\/doi.org\/10.1186\/s12936-021-03842-8","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,12]]},"assertion":[{"value":"22 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All blood samples used were taken as part of routine (planned) blood sampling for (malaria) diagnostics (rapid diagnostic testing and microscopy). No additional blood was drawn. Furthermore, no patients were subjected to additional procedures or were required to follow rules of behaviour. Therefore, the Medical Research Involving Human Subjects Act (WMO) does not apply as has been confirmed in writing by the Medical Research Ethics Committee (MREC) Utrecht (reference number MvdL\/mb\/21\/500322).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. No individual person\u2019s data in any form is presented in our manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ARS is an employee of MRC Holland. All other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"314"}}